Filip Janku
M.D. Anderson Cancer Center
4
4
3
N/A
0
6
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+6 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Sriram Yennu
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
David Hui
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Lorenzo Cohen
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Siqing fu
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Shannon N Westin
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
A P Chen
National Cancer Institute LAO
Shared therapeutic areas:
Worked with same sponsors:
Jennifer Ligibel, MD
Dana-Farber Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Shannon Westin
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Matthew Krebs, Dr
The Christie Hospital
Shared therapeutic areas:
Everett Lohman, Dsc
Loma Linda University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Dabrafenib and Trametinib in Treating Patients With Erdheim Chester Disease With BRAF V600 Mutations
Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients
Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers
Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations
All 4 trials loaded